rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Seth Herbst

Director

Company insider

Files Form 4 as: Director, Dyadic International.

In numbers

Trades disclosed
30
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
2 Jan 2020
Last trade
2 Jan 2026
Last filed
6 Jan 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
DYAI Dyadic InternationalDirector · Biotechnology · last 2 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 6 Jan 2026DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M—21,552filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—21,552 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—21,552 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—39,894 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—39,894 at $0.00filing
2 Jan 2026filed 6 Jan 2026DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M—21,552filing
6 Jan 2025filed 8 Jan 2025DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M$18K18,750 at $0.97filing
6 Jan 2025filed 8 Jan 2025DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M$6,0636,250 at $0.97filing
2 Jan 2025filed 7 Jan 2025DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—23,585 at $0.00filing
2 Jan 2025filed 7 Jan 2025DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jan 2025filed 7 Jan 2025DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—21,552 at $0.00filing
2 Jan 2025filed 7 Jan 2025DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M—23,585filing
6 Jan 2024filed 8 Jan 2025DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—18,750 at $0.00filing
6 Jan 2024filed 8 Jan 2025DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—6,250 at $0.00filing
3 Jan 2024filed 4 Jan 2024DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code M—27,174 at $0.00filing
3 Jan 2024filed 4 Jan 2024DYAI Dyadic InternationalBiotechnologySEC FORM 4 Code M—27,174filing
2 Jan 2024filed 4 Jan 2024DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jan 2024filed 4 Jan 2024DYAI Dyadic Internationaloption or derivative · BiotechnologySEC FORM 4 Code A—23,585 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Francisco Trust under agreement dated February 28, 199610% owner · 10% owner at Dyadic International, filing Form 4 there in the last year
Jack KayeDirector · Director at Dyadic International, filing Form 4 there in the last year
Mark A. EmalfarbCEO · CEO at Dyadic International, filing Form 4 there in the last year
Ronen TcheletVP of Research and Bus. Dvlpmt · VP of Research and Bus. Dvlpmt at Dyadic International, filing Form 4 there in the last year
Ping Wang RawsonChief Financial Officer · Chief Financial Officer at Dyadic International, filing Form 4 there in the last year